Quantitative proteomics for post-translational modification and histone epigenetics

June 11, 2005

Dr. Zhongyi Cheng, the CEO of PTM Biolabs Inc, visited our lab and shared his great research experience in quantitative proteomics for post-translational modification and histone epigenetics with us at E104.